Zobrazeno 1 - 3
of 3
pro vyhledávání: '"H. H.-M. Elsnukaeva"'
Autor:
M. Yu. Fedyanin, E. M. Polyanskaya, H. H.-M. Elsnukaeva, A. A. Tryakin, I. A. Pokataev, A. A. Bulanov, S. A. Tjulandin
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 125-132 (2020)
Introduction. Based on the subgroup analysis of the TRIBE study FOLFOXIRI with bevacizumab is the recommended option for patients (pts) with mBRAF metastatic colorectal cancer (mCRC) in the 1st line. However, subgroup analysis of other studies showed
Externí odkaz:
https://doaj.org/article/ee57e07abaa94e0ca701173d11ac940a
Publikováno v:
Успехи молекулярной онкологии, Vol 4, Iss 1, Pp 24-34 (2017)
There are a lot of studies that dedicated to genetic differences between the primary tumor and metastases. This becomes relevant not only for molecular biologists for understanding carcinogenesis, but also becoming increasingly important for medical
Externí odkaz:
https://doaj.org/article/3bc03d508e7b4a83b12328521707c707
Autor:
M. Yu. Fedyanin, H. H.‑M. Elsnukaeva, I. A. Demidova, D. L. Stroyakovskii, Yu. A. Shelygin, A. S. Tsukanov, Yu. S. Sergeev, A. A. Ponomarenko, M. V. Panina, V. P. Shubin, F. V. Moiseenko, E. Yu. Karpenko, L. V. Bolotina, A. V. Kudriavtseva, M. L. Filipenko, M. E. Voskoboev, I. P. Oskorbin, L. Yu. Vladimirova, O. I. Kit, A. M. Stroganova, S. L. Dranko, A. I. Senderovich, A. A. Tryakin, S. A. Tjulandin
Publikováno v:
Malignant tumours. 11:5-14
Introduction: local treatment of metastases is an integral part of colon cancer treatment. However, there is not enough data on the efficacy of surgical resection of metastases in patients with a BRAF gene mutation to recom‑mend this approach in ro